AMGN.NASDAQAmgen INC

Form 4: Amgen SVP Derek Miller Reports Stock Disposal to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Amgen's SVP of Human Resources, Derek Miller, disposed of 930 shares of common stock on March 17, 2025, to cover tax obligations arising from vested restricted stock units.

Summary

  • On March 17, 2025, Derek Miller, SVP of Human Resources at Amgen Inc., disposed of 930 shares of Amgen common stock.
  • The transaction was executed at a price of $313.71 per share.
  • This disposal was conducted to satisfy tax obligations related to vested restricted stock units (RSUs).
  • Following the transaction, Miller directly owns 9,654 shares of Amgen common stock, which includes 174 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to an insider stock transaction for tax purposes. It doesn't convey any particularly positive or negative sentiment about the company's performance or prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders. This transaction appears routine, related to tax obligations from vested equity.

Comparison to Industry Standards

  • Form 4 filings are a standard regulatory requirement for publicly traded companies in the United States, ensuring transparency in insider trading activities.
  • Companies like Johnson & Johnson, Pfizer, and Merck also have their executives file similar forms when they engage in transactions involving their company's stock.
  • The number of shares sold is relatively small compared to the total outstanding shares of Amgen, suggesting it is unlikely to have a significant impact on the stock price.

Stakeholder Impact

  • The transaction is unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors, as it is a routine insider transaction.

Key Dates

DateDescription
03/17/2025Date of stock disposal transaction.
03/18/2025Date of signature on the Form 4 filing.

Keywords

Form 4, Amgen, Derek Miller, Stock Disposal, Insider Trading, Tax Obligations, RSUs, Dividend Equivalents

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.